文献速递心境障碍儿童青少年精神会诊联络精神医学

母亲产前抑郁与代谢改变相关,可预测出生结局及儿童神经发育与心理健康

Maternal Antenatal Depression Is Associated With Metabolic Alterations That Predict Birth Outcomes and Child Neurodevelopment and Mental Health.
PubMed 文献 · Biol Psychiatry · 2024-08-08

在331对母子队列中,产前抑郁(AD)与15项代谢指标相关,这些指标共同解释AD方差25%,并提高对AD、出生结局、发育里程碑及儿童精神行为障碍的预测方差。结果在416对母子独立队列中重复验证。

要点

  • AD与15项代谢指标相关,共同解释AD方差25%(p<.0001)。
  • 代谢指标在AD危险因素基础上增加AD方差解释量(32.3% vs 12.6%)。
  • 代谢指标在AD、儿童性别和年龄基础上提高出生及神经发育结局预测方差。

核心结论

  • AD与15项代谢指标改变相关,这些指标共同改善对AD及其危险因素和儿童出生、神经发育及心理健康结局的预测。
  • 这些代谢指标可能成为识别高危母亲和儿童以进行个性化干预的生物标志物。

研究设计与样本

  • 在331对母子队列中研究AD(医学登记诊断史和/或孕期流行病学研究中心抑郁量表评分≥20)与孕期3次检测的95项代谢指标之间的关联。
  • 检验AD相关代谢指标是否在AD危险因素基础上增加AD方差解释量,以及在AD基础上增加分娩、神经发育和心理健康结局的方差解释量。
  • 在416对母子独立队列中重复验证结果。

主要发现

  • 弹性网络回归识别出15项代谢指标,共同解释AD方差25%(p<.0001),包括氨基酸和脂肪酸、葡萄糖、炎症和脂质。
  • 这些代谢指标在AD危险因素基础上增加AD方差解释量(32.3%,p<.0001 vs 12.6%,p=.004)。
  • 在AD、儿童性别和年龄基础上,代谢指标增加儿童胎龄方差解释量(9.0%,p<.0001 vs 0.7%,p=.34)、出生体重(9.0%,p=.03 vs 0.7%,p=.33)、2.3至5.7岁发育里程碑(21.0%,p=.002 vs 11.6%,p<.001)及13.1至16.8岁前任何精神或行为障碍(25.2%,p=.03 vs 5.0%,p=.11)。
  • 上述发现在独立队列中重复验证。

关键数值与推荐

  • AD定义:医学登记诊断史和/或孕期流行病学研究中心抑郁量表评分≥20。
  • 弹性网络回归识别15项代谢指标,共同解释AD方差25%(p<.0001)。
  • 代谢指标在AD危险因素基础上增加AD方差解释量(32.3%,p<.0001 vs 12.6%,p=.004)。
  • 代谢指标在AD、儿童性别和年龄基础上增加儿童胎龄方差解释量(9.0%,p<.0001 vs 0.7%,p=.34)、出生体重(9.0%,p=.03 vs 0.7%,p=.33)、2.3至5.7岁发育里程碑(21.0%,p=.002 vs 11.6%,p<.001)及13.1至16.8岁前任何精神或行为障碍(25.2%,p=.03 vs 5.0%,p=.11)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence regarding metabolic alterations associated with maternal antenatal depression (AD) is limited, and their role as potential biomarkers that improve the prediction of AD and adverse childbirth, neurodevelopmental, and mental health outcomes remains unexplored. METHODS: In a cohort of 331 mother-child dyads, we studied associations between AD (a history of medical register diagnoses and/or a Center for Epidemiological Studies Depression Scale score during pregnancy ≥ 20) and 95 metabolic measures analyzed 3 times during pregnancy. We tested whether the AD-related metabolic measures increased variance explained in AD over its risk factors and in childbirth, neurodevelopmental, and mental health outcomes over AD. We replicated the findings in a cohort of 416 mother-child dyads. RESULTS: Elastic net regression identified 15 metabolic measures that collectively explained 25% (p < .0001) of the variance in AD, including amino and fatty acids, glucose, inflammation, and lipids. These metabolic measures increased the variance explained in AD over its risk factors (32.3%, p < .0001 vs. 12.6%, p = .004) and in child gestational age (9.0%, p < .0001 vs. 0.7%, p = .34), birth weight (9.0%, p = .03 vs. 0.7%, p = .33), developmental milestones at the age of 2.3 to 5.7 years (21.0%, p = .002 vs. 11.6%, p < .001), and any mental or behavioral disorder by the age of 13.1 to 16.8 years (25.2%, p = .03 vs. 5.0%, p = .11) over AD, child sex, and age. These findings were replicated in the independent cohort. CONCLUSIONS: AD was associated with alterations in 15 metabolic measures, which collectively improved the prediction of AD over its risk factors and birth, neurodevelopmental, and mental health outcomes in children over AD. These metabolic measures may become biomarkers that can be used to identify at-risk mothers and children for personalized interventions.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Girchenko P, Lahti-Pulkkinen M, Laivuori H, et al. Maternal Antenatal Depression Is Associated With Metabolic Alterations That Predict Birth Outcomes and Child Neurodevelopment and Mental Health. Biol Psychiatry. 2024. PMID: 39127233. doi:10.1016/j.biopsych.2024.07.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。